BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15126771)

  • 1. Emerging role of botulinum toxin in the management of voiding dysfunction.
    Smith CP; Chancellor MB
    J Urol; 2004 Jun; 171(6 Pt 1):2128-37. PubMed ID: 15126771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin treatment of urethral and bladder dysfunction.
    Chuang YC; Smith CP; Somogyi GT; Chancellor MB
    J Formos Med Assoc; 2003 Jan; 102(1):5-11. PubMed ID: 12684605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin as a new therapy option for voiding disorders: current state of the art.
    Leippold T; Reitz A; Schurch B
    Eur Urol; 2003 Aug; 44(2):165-74. PubMed ID: 12875934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.
    Cruz F; Silva C
    Curr Opin Urol; 2004 Nov; 14(6):329-34. PubMed ID: 15626874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
    Sahai A; Khan M; Fowler CJ; Dasgupta P
    Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin treatment of urethral and bladder dysfunction.
    Yokoyama T; Kumon H; Smith CP; Somogyi GT; Chancellor MB
    Acta Med Okayama; 2002 Dec; 56(6):271-7. PubMed ID: 12685855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction.
    Phelan MW; Franks M; Somogyi GT; Yokoyama T; Fraser MO; Lavelle JP; Yoshimura N; Chancellor MB
    J Urol; 2001 Apr; 165(4):1107-10. PubMed ID: 11257648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction.
    Smith CP; Somogyi GT; Chancellor MB
    Curr Urol Rep; 2002 Oct; 3(5):382-7. PubMed ID: 12354347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection for lower urinary tract dysfunction.
    Kuo YC; Kuo HC
    Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of botulinum toxin in the prostate.
    Chuang YC; Chancellor MB
    J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unusual history and the urological applications of botulinum neurotoxin.
    Hanchanale VS; Rao AR; Martin FL; Matanhelia SS
    Urol Int; 2010; 85(2):125-30. PubMed ID: 20664247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in urology: evaluation using an evidence-based medicine approach.
    Smith CP; Somogyi GT; Boone TB
    Nat Clin Pract Urol; 2004 Nov; 1(1):31-7. PubMed ID: 16474464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Botulinum toxin in urogynaecology.
    Sinha D; Karri K; Arunkalaivanan AS
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):4-11. PubMed ID: 17275980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urologic applications of botulinum toxin therapy for voiding dysfunction.
    Rackley R; Abdelmalak J
    Curr Urol Rep; 2004 Oct; 5(5):381-8. PubMed ID: 15461917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for conditions of the female pelvis.
    El-Khawand D; Wehbe S; Whitmore K
    Int Urogynecol J; 2013 Jul; 24(7):1073-81. PubMed ID: 23344218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detrusor-sphincter dyssynergia and botulinum toxin].
    Parratte B; Bonniaud V; Tatu L; Metton G; Michel F; Cosson A; Monnier G
    Ann Readapt Med Phys; 2003 Jul; 46(6):319-25. PubMed ID: 12928137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the vicious circle: Onabotulinum toxin A in children with therapy-refractory dysfunctional voiding.
    't Hoen LA; van den Hoek J; Wolffenbuttel KP; van der Toorn F; Scheepe JR
    J Pediatr Urol; 2015 Jun; 11(3):119.e1-6. PubMed ID: 25794865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urological applications of botulinum toxins].
    Karsenty G; Corcos J; Schurch B
    Prog Urol; 2006 Jun; 16(3):263-74. PubMed ID: 16821335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of botulinum toxin for treatment of lower urinary tract symptoms.
    Lucioni A; Reynolds WS; Rapp DE; Katz M; Bales GT
    Minerva Urol Nefrol; 2008 Jun; 60(2):93-103. PubMed ID: 18500224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.